Wacker Neuson SE (WAC)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 22.50 |
|---|---|
| 52-week range | 16.66 – 26.05 |
| Return, 1 month / 3 months | −5.7% / +2.5% |
| Return, 1 year / 3 years | +20.8% / +47.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 47.0% |
| Worst drawdown (1 year) | -32.5% |
| Average daily value traded | 1.28M EUR |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wacker Neuson SE is a German manufacturer of construction equipment and compact machines. Its products include excavators, wheel loaders, dumpers and compactors, along with light equipment such as rammers, vibratory plates and breakers, and concrete technology for finishing work. The company supplies construction contractors, rental firms, landscapers, farmers and municipal operators through dealers and its own sales network. It is based in Munich, Germany, and serves customers in many countries.
On this site Wacker Neuson SE appears as a stock on the XETRA Stock Exchange (Germany), code WAC, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wacker Neuson SE (WAC) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 22.50 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 188 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.8% and over the last three months it rose 2.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.6% | ||
| From 52-week high | -12.5% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 2.5% | ||
| 6-month return | 18.0% | ||
| 12-month return, skipping the last month | 28.1% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 47.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.5% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 1.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −5.7% |
| 3 months | +2.5% |
| 6 months | +18.0% |
| 1 year | +20.8% |
| 3 years | +47.0% |
| 5 years | +5.6% |
Signals
| 50-day / 200-day average | 23.03 / 20.35 |
|---|---|
| Golden / death cross (60 days) | Golden, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 May 2026 | EUR 0.7000 |
| 26 May 2025 | EUR 0.6000 |
| 16 May 2024 | EUR 1.1500 |
| 29 May 2023 | EUR 1.0000 |
| 6 Jun 2022 | EUR 0.9000 |
| 27 May 2021 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.